Aytu Biopharma, Inc (AYTU) insider trading

Every open-market stock purchase and sale by Aytu Biopharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Joshua R. Disbrow (CEO), $100K, 16 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent AYTU insider trades

DateInsiderTradeValue
Oct 3, 2025Carl Dockery (Director)Bought (not open market)—
Oct 3, 2025Greg Pyszczymuka (C-suite exec)Bought (not open market)—
Oct 3, 2025Jarrett Disbrow (C-suite exec)Bought (not open market)—
Oct 3, 2025Joshua R. Disbrow (CEO)Bought (not open market)—
Oct 3, 2025Joshua R. Disbrow (CEO)Bought (not open market)—
Oct 3, 2025Ryan J Selhorn (CFO)Bought (not open market)—
Oct 3, 2025Ryan J Selhorn (CFO)Bought (not open market)—
Oct 3, 2025Abhinav Jain (Director)Bought (not open market)—
Oct 3, 2025Vivian H Liu (Director)Bought (not open market)—
Oct 3, 2025Jarrett Disbrow (C-suite exec)Bought (not open market)—
Oct 3, 2025John Donofrio Jr. (Director)Bought (not open market)—

Who's trading AYTU

Get free alerts when an insider at Aytu Biopharma, Inc files a new trade →